Search clinical trials for: Growth hormone releasing factor/Growth hormone releasing hormone

Total 62821 results

Ipsen

Completed

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients (ANAREN)

Prostate Cancer

Spain
Genentech, Inc.

Terminated

A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Breast Cancer

United States, Korea, Republic of, Spain, Netherlands
Steno Diabetes Center Copenhagen

Completed

Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes

Diabetes Mellitus, Type 1

Denmark
University of Pennsylvania
National Institute on Aging (NIA)

Completed

Mechanistic Study of Subclinical Hypothyroidism In the Elderly

Subclinical Hypothyroidism

United States
University of Cagliari

Unknown

Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Adenomyosis | Chronic Pelvic Pain
Fudan University

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

Endometrial Neoplasm Malignant Stage I

China
University of Sao Paulo
Escola Bahiana de Medicina e Saude Publica

Completed

Contraception in Women With Sickle Cell Disease

Sickle Cell Disease

Brazil
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaborators

Completed

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Australia, Peru, Puerto Rico
European Organisation for Research and Treatment...

Withdrawn

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer (ARN-509)

Prostate Cancer
Istanbul Training and Research Hospital

Withdrawn

Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

Contraceptive Methods Comparison

Turkey
Alkü Alanya Education and Research Hospital

Unknown

PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS

Uterine Fibroid | Gonadotropin-Releasing Hormone-Dependent Precocious Puberty

Turkey
Fudan University
Zhejiang Cancer Hospital; Shanghai 6th People's Hospital; Shanghai Changning...

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia

China
Ipsen

Completed

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy (PRISME)

Prostate Cancer

France
Cairo University

Unknown

Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET

Infertility

Egypt
Columbia University

Completed

Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in Botswana

HIV Infections | Contraceptive Usage | Drug Interaction

Botswana
Tampere University Hospital

Completed

Luteal Phase Support in Insemination Cycles

Infertility, Female

Finland
Parc de Salut Mar

Completed

Generation of Biological Samples Positive to Triptorelin for Anti-doping Control (TRIPTO)

Healthy Volunteers

Spain
University of Southern California

Unknown

Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

Ovulation; Failure or Lack of
Centre Hospitalier Universitaire de Saint Etienne

Completed

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study (IDEXACOR)

Keratoconus | Fuchs' Endothelial Dystrophy | Congenital Hereditary Stromal Dystrophy of the Cornea

France
CONRAD
United States Agency for International Development (USAID); Agility Clinical...

Completed

Safety, PK, and PD Study of IVRs Releasing TFV and LNG (TFV/LNG IVR)

Contraceptive Usage | Anti-Infective Agents | Anti-Retroviral Agents

Dominican Republic, United States
Ferring Pharmaceuticals

Completed

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. (ProComD)

Advanced Prostate Cancer

Germany
RenJi Hospital

Unknown

Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome | Infertility | Ovulation Disorder

China
Rabin Medical Center
Ferring Pharmaceuticals

Completed

Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists

Cardiovascular Diseases | Prostatic Neoplasms

Israel
Oregon Health and Science University

Completed

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Metrorrhagia | Menorrhagia | Medicated Intrauterine Devices

United States
Bayer

Terminated

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

Contraception

Germany, Netherlands, United Kingdom
Children's Mercy Hospital Kansas City

Withdrawn

Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia

Functional Dyspepsia

United States
Region Örebro County
Uppsala-Örebro Regional Research Council

Completed

Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty

Puberty, Precocious

Sweden
Assiut University

Completed

Triggering of Follicular Maturation

Increase Pregnancy Rate

Egypt
University of Nottingham

Unknown

Systemic Hormones and Muscle Protein Synthesis

Sarcopenia | Muscle Atrophy | Muscle Hypotrophy

United Kingdom
Ipsen

Completed

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues (ANALUTS)

Prostate Cancer

Spain, Portugal
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
UConn Health
Schering-Plough

Terminated

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

Ovarian Hyperstimulation Syndrome | Endometrial Receptivity

United States
University of Louisville

Terminated

Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement (IUD)

Contraception

United States
AbbVie (prior sponsor, Abbott)

Completed

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (ELARIS EM-I)

Endometriosis
AbbVie

Completed

A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (ELARIS EM-II)

Endometriosis
Göteborg University

Completed

Acupuncture and Gonadotropin-releasing Hormone Pulse Generator and Stress Axis in Polycystic Ovary Syndrome (PCOSLFEA)

Polycystic Ovary Syndrome

Sweden
Lawson Health Research Institute

Terminated

FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer (FASTR)

Prostate Cancer

Canada
National Institute of Diabetes and Digestive and...

Completed

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

Healthy | Pituitary Disease | Thyroid Disease

United States
University of Washington
OSI Pharmaceuticals

Completed

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Prostate Cancer

United States
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation (ARTIST)

Polycystic Ovary Syndrome

Germany
Cairo University
Nile Ivf Center, Cairo, Egypt; Kamal Shaeer center of infertility

Completed

Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

Infertility

Egypt
University of Michigan

Completed

Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures

Stress

United States
Nova Clinic, Russia

Unknown

Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response

Infertility, Female | Ovarian Stimulation | In Vitro Fertilisation

Russian Federation
UConn Health
Susan G. Komen Breast Cancer Foundation; Hollfelder foundation

Terminated

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Cancer-related Fatigue

United States
Ginegorama S.L.

Unknown

Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)

Infertility, Female | Ovulation Induction | In Vitro Fertilization (IVF) | Oocytes

Spain
Benha University

Unknown

Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

Infertility, Female

Egypt
Peking Union Medical College Hospital

Completed

Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer (POF)

Breast Cancer
National Institute of Diabetes and Digestive and...

Completed

Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3

Healthy | Thyroid Disease

United States

3

Subscribe